Helix BioMedix, Inc. (HXBM)
OTCMKTS · Delayed Price · Currency is USD
6.50
0.00 (0.00%)
At close: Sep 3, 2026
Helix BioMedix Market Cap
Helix BioMedix has a market cap or net worth of $1.24 million as of September 8, 2026. Its market cap has increased by 22.22% in one year.
Market Cap
1.24M
Enterprise Value
n/a
Revenue
2.07M
Ranking
n/a
PE Ratio
n/a
Stock Price
$6.50
ChartMarket Cap Chart
Since July 26, 1995, Helix BioMedix's market cap has decreased from 1.59M to 1.24M, a decrease of -22.50%. That is a compound annual growth rate of -0.82%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2026 | 1.24M | 175.00% |
| Dec 31, 2025 | 449.42K | -75.00% |
| Dec 26, 2024 | 1.80M | -76.87% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BioAtla | 2.20M |
| Vaccinex | 2.01M |
| Protagenic Therapeutics | 1.92M |
| Vaxxinity | 1.90M |
| Avenue Therapeutics | 1.79M |
| AXIM Biotechnologies | 1.37M |
| Sirona Biochem | 1.35M |
| Abpro Holdings | 1.35M |